Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Coagulation
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Platelet disorders=== Platelet disorders are either congenital or acquired. Examples of congenital platelet disorders are [[Glanzmann's thrombasthenia]], [[Bernard–Soulier syndrome]] (abnormal [[Glycoprotein Ib-IX-V Receptor Complex|glycoprotein Ib-IX-V complex]]), [[gray platelet syndrome]] (deficient [[alpha granules]]), and [[delta storage pool deficiency]] (deficient [[dense granules]]). Most are rare. They predispose to hemorrhage. [[Von Willebrand disease]] is due to deficiency or abnormal function of [[von Willebrand factor]], and leads to a similar bleeding pattern; its milder forms are relatively common.{{Citation needed|date=November 2021}} Decreased platelet numbers (thrombocytopenia) is due to insufficient production (e.g., [[myelodysplastic syndrome]] or other bone marrow disorders), destruction by the immune system ([[immune thrombocytopenic purpura]]), or consumption (e.g., [[thrombotic thrombocytopenic purpura]], [[hemolytic-uremic syndrome]], [[paroxysmal nocturnal hemoglobinuria]], [[disseminated intravascular coagulation]], [[heparin-induced thrombocytopenia]]).<ref>{{Cite web |title=Disseminated Intravascular Coagulation |url=https://www.lecturio.com/concepts/disseminated-intravascular-coagulation/ |url-status=live |archive-url=https://web.archive.org/web/20210712111249/https://www.lecturio.com/concepts/disseminated-intravascular-coagulation/ |archive-date=12 July 2021 |access-date=12 July 2021 |website=The Lecturio Medical Concept Library}}</ref> An increase in platelet count is called [[thrombocytosis]], which may lead to formation of [[Thrombosis|thromboembolisms]]; however, thrombocytosis may be associated with increased risk of either thrombosis or hemorrhage in patients with [[myeloproliferative neoplasm]].<ref>{{Cite journal |vauthors=Andreescu M, Andreescu B |date=March 2024 |title=A Review About the Assessment of the Bleeding and Thrombosis Risk for Patients With Myeloproliferative Neoplasms Scheduled for Surgery |journal=Cureus |volume=16 |issue=3 |page=e56008 |doi=10.7759/cureus.56008 |pmc=11007487 |pmid=38606222 |doi-access=free}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)